Literature DB >> 384895

Importance of medium in demonstrating penicillin tolerance by group B streptococci.

K S Kim, R N Yoshimori, D T Imagawa, B F Anthony.   

Abstract

A total of 30 clinical isolates of group B streptococci were studied for penicillin tolerance in vitro. Minimal inhibitory and bactericidal concentrations of penicillin were determined simultaneously in three test media which have been used for group B streptococci, tryptose phosphate, Mueller-Hinton, and Todd-Hewitt broths, using a logarithmic-phase inoculum of 10(5) colony-forming units per ml. Minimal inhibitory concentrations in the three media did not differ significantly. However, minimal bactericidal concentrations were significantly higher in tryptose phosphate broth (mean, 1.04 mug/ml) than in Mueller-Hinton broth (0.22 mug/ml) or Todd-Hewitt broth (0.15 mug/ml). Similarly, ratios of minimal bactericidal to minimal inhibitory concentrations were significantly greater in tryptose phosphate broth than in Mueller-Hinton or Todd-Hewitt broth. After incubation in tryptose phosphate broth for an additional 24 h, the minimal bactericidal concentration consistently fell to levels which were only twice or equal to the minimal inhibitory concentration. This study illustrates the importance of the medium in the demonstration of penicillin tolerance and of controlling laboratory variables in the susceptibility testing of group B streptococci with penicillin.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 384895      PMCID: PMC352824          DOI: 10.1128/AAC.16.2.214

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Group B streptococcus in a general hospital.

Authors:  B F Anthony; N F Concepcion
Journal:  J Infect Dis       Date:  1975-11       Impact factor: 5.226

2.  Concentrations of bacteria in cerebrospinal fluid of patients with bacterial meningitis.

Authors:  W E Feldman
Journal:  J Pediatr       Date:  1976-04       Impact factor: 4.406

3.  Antimicrobial susceptibility of group B streptococci isolated from a variety of clinical sources.

Authors:  C J Baker; B J Webb; F F Barrett
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

4.  Group B streptococcal meningitis: delayed response to treatment.

Authors:  K Edwards; P Ferrieri; T R Thompson; A T Davis
Journal:  Childs Brain       Date:  1977

5.  Discrepancy between minimum inhibitory and minimum bactericidal concentrations of penicillin for group A and group B beta-hemolytic streptococci.

Authors:  J L Allen; K Sprunt
Journal:  J Pediatr       Date:  1978-07       Impact factor: 4.406

6.  Bactericidal studies of penicillin-gentamicin combinations against group B streptococci.

Authors:  G D Overturf; M Horowitz; J Wilkins; J Leedom; E Steinberg
Journal:  J Antibiot (Tokyo)       Date:  1977-06       Impact factor: 2.649

7.  Multiple antibiotic resistance in a bacterium with suppressed autolytic system.

Authors:  A Tomasz; A Albino; E Zanati
Journal:  Nature       Date:  1970-07-11       Impact factor: 49.962

8.  Relapse during penicillin treatment of group B streptococcal meningitis.

Authors:  R D Dorand; G Adams
Journal:  J Pediatr       Date:  1976-08       Impact factor: 4.406

9.  Antibiotic-killing kinetics of group B streptococci.

Authors:  V Schauf; A Deveikis; L Riff; A Serota
Journal:  J Pediatr       Date:  1976-08       Impact factor: 4.406

10.  A new type of penicillin resistance of Staphylococcus aureus.

Authors:  L D Sabath; N Wheeler; M Laverdiere; D Blazevic; B J Wilkinson
Journal:  Lancet       Date:  1977-02-26       Impact factor: 79.321

View more
  16 in total

Review 1.  Serum bactericidal test.

Authors:  C W Stratton
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

2.  Evaluation of oxacillin tolerance in Staphylococcus aureus by a novel method.

Authors:  B F Woolfrey; R T Lally; M N Ederer
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191

Review 3.  Problems in in vitro determination of antibiotic tolerance in clinical isolates.

Authors:  J C Sherris
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

4.  Macrodilution MBC result reproducibility for methicillin-susceptible and reputedly tolerant Staphylococcus aureus isolates.

Authors:  B F Wolfrey; R T Lally
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

5.  Ampicillin killing curve patterns for ampicillin-susceptible nontypeable Haemophilus influenzae strains by the agar dilution plate count method.

Authors:  B F Woolfrey; M A Enright
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

6.  Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci.

Authors:  C Betriu; M Gomez; A Sanchez; A Cruceyra; J Romero; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

7.  Variables in demonstrating methicillin tolerance in Staphylococcus aureus strains.

Authors:  K Ishida; P A Guze; G M Kalmanson; K Albrandt; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

8.  Effect of rifampin on ampicillin killing of group B streptococci.

Authors:  S M Smith; R H Eng; S Landesman
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

9.  Susceptibility of group B streptococci to 16 beta-lactam antibiotics, including new penicillin and cephalosporin derivatives.

Authors:  M R Jacobs; F Kelly; W T Speck
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

10.  Bactericidal synergy between penicillin or ampicillin and aminoglycosides against antibiotic-tolerant lactobacilli.

Authors:  A S Bayer; A W Chow; J O Morrison; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.